Erik Cederfjäll, Ph.D. - Publications

Affiliations: 
2008-2014 B.R.A.I.N.S. Unit Lund University, Lund, Skåne län, Sweden 
 2015-2017 Molecules - Signaling - Development Max Planck Institute of Neurobiology, Jupiter, FL, United States 
Area:
Parkinson's disease | Gene therapy

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Cederfjäll E, Broom L, Kirik D. Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 896-906. PMID 25592335 DOI: 10.1038/mt.2015.8  0.96
2013 Cederfjäll E, Nilsson N, Sahin G, Chu Y, Nikitidou E, Björklund T, Kordower JH, Kirik D. Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease. Scientific Reports. 3: 2157. PMID 23831692 DOI: 10.1038/srep02157  0.96
2012 Cederfjäll E, Sahin G, Kirik D, Björklund T. Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1315-26. PMID 22294150 DOI: 10.1038/mt.2012.1  0.96
2012 Cederfjäll E, Sahin G, Kirik D. Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain. Neurobiology of Disease. 48: 222-7. PMID 22048069 DOI: 10.1016/j.nbd.2011.10.017  0.96
2010 Björklund T, Cederfjäll EA, Kirik D. Gene therapy for dopamine replacement. Progress in Brain Research. 184: 221-35. PMID 20887878 DOI: 10.1016/S0079-6123(10)84012-9  0.96
2010 Björklund T, Carlsson T, Cederfjäll EA, Carta M, Kirik D. Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease. Brain : a Journal of Neurology. 133: 496-511. PMID 20129936 DOI: 10.1093/brain/awp314  0.96
Show low-probability matches.